1-7 of 7
Eve Gallop-Evans
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bendamustine Plus Brentuximab Has Superior Efficacy to Brentuximab Monotherapy As Third-Line Treatment for Classical Hodgkin Lymphoma: A Real-World, Multicentre UK Analysis

Rohan Shotton, Amy A Kirkwood, Michael Northend, Dina Fathoala, Kieran Burton, Graeme Ferguson, Laura Aiken, Caroline Shrubsole, Lauren Henry, Mary Owen, Rebecca Oliver, Nicolas Martinez-Calle, Astrid Etherington, Eve Gallop-Evans, Cathy Burton, Fiona Miall, Wendy Osborne, Rifca Le Dieu, Pamela McKay, Satyen H Gohil, Graham P. Collins, Elizabeth H Phillips
Journal: Blood
Blood (2023) 142 (Supplement 1): 6173.
https://doi.org/10.1182/blood-2023-186601
Published: 2023
Journal Articles

Adjuvant Systemic Therapy in High Risk Solitary Bone Plasmacytoma: Results of the UK Randomised Phase III IDRIS Study (CR UK/14/032)

Kushani Ediriwickrema, Neil K Rabin, Shirley D'Sa, Graham Jackson, Peter Hoskin, Eve Gallop-Evans, Patricia Diez, Catherine Parbutt, Andre Lopes, Sevasti Galani, Laura Clifton-Hadley, Darren Edwards, Husne Timur Tezver, Ruth M. de Tute, Andrew Bates, Roger G Owen
Journal: Blood
Blood (2022) 140 (Supplement 1): 12626–12627.
https://doi.org/10.1182/blood-2022-158528
Published: 2022
Journal Articles

Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy

Anna Santarsieri, Emily Mitchell, Katherine Sturgess, Pauline Brice, Tobias F. Menne, Wendy Osborne, Thomas Creasey, Kirit M. Ardeshna, Sarah Behan, Kaljit Bhuller, Stephen Booth, Nikesh D. Chavda, Graham P. Collins, Dominic J. Culligan, Kate Cwynarski, Andrew Davies, Abigail Downing, David Dutton, Michelle Furtado, Eve Gallop-Evans, Andrew Hodson, David Hopkins, Hannah Hsu, Sunil Iyengar, Stephen G. Jones, Kim M. Linton, Oliver C. Lomas, Nicolas Martinez-Calle, Abhinav Mathur, Pamela McKay, Sateesh K. Nagumantry, Deirdre O'Mahony, Elizabeth H. Phillips, Neil Phillips, John F. Rudge, Nimish K. Shah, Gwyneth Stafford, Alex Sternberg, Rachel Trickey, Benjamin J. Uttenthal, Natasha Wetherall, Andrew K. McMillan, Michael Stratton, Elisa Laurenti, Peter J. Campbell, George A. Follows
Journal: Blood
Blood (2022) 140 (Supplement 1): 1761–1764.
https://doi.org/10.1182/blood-2022-166543
Published: 2022
Journal Articles

Real World Escalated Beacopdac Delivers Similar Outcomes to Escalated Beacopp and Superior Outcomes to Response-Adapted (RATHL) ABVD, While Potentially Reducing Toxicity Compared with Escalated Beacopp

Anna Santarsieri, Katherine Sturgess, Pauline Brice, Tobias F Menne, Wendy Osborne, Thomas Creasey, Kirit M. Ardeshna, Sarah Behan, Kaljit Bhuller, Stephen Booth, Graham P. Collins, Kate Cwynarski, Andrew Davies, Michelle Furtado, Eve Gallop-Evans, Andrew Hodson, Sunil Iyengar, Stephen G Jones, Kim Linton, Nicolas Martinez-Calle, Pamela McKay, Sateesh K Nagumantry, Deirdre O'Mahony, Beth Phillips, Neil Phillips, John F Rudge, Nimish Shah, Gwyneth Stafford, Alex Sternberg, Rachel Trickey, Benjamin J Uttenthal, Nathasha Wetherall, Andrew K McMillan, George A Follows
Journal: Blood
Blood (2021) 138 (Supplement 1): 877.
https://doi.org/10.1182/blood-2021-146242
Published: 2021
Journal Articles

Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study

Clinical Trials & Observations
Myron S. Czuczman, Luis Fayad, Vincent Delwail, Guillaume Cartron, Eric Jacobsen, Kazimierz Kuliczkowski, Brian K. Link, Lauren Pinter-Brown, John Radford, Andrzej Hellmann, Eve Gallop-Evans, Christine G. DiRienzo, Nancy Goldstein, Ira Gupta, Roxanne C. Jewell, Thomas S. Lin, Steen Lisby, Martin Schultz, Charlotte A. Russell, Anton Hagenbeek
Journal: Blood
Blood (2012) 119 (16): 3698–3704.
https://doi.org/10.1182/blood-2011-09-378323
Published: 2012
Includes: Supplemental data
Journal Articles

Ofatumumab Monotherapy for Treatment of Patients with Relapsed/Progressive Diffuse Large B-Cell Lymphoma: Results From a Multicenter Phase II Study

Bertrand Coiffier, MD, PhD, André Bosly, MD, Ka Lung Wu, MD, PhD, Gregor Verhoef, MD, PhD, Van Eygen Koen, MD, Giovanni Martinelli, MD, Gabriela Barca, MD, PhD, Andrew Davies, MRCP, PhD, Eve Gallop-Evans, PhD, Swaminathan Padmanabhan, MBBS, MS, Ira V. Gupta, MD, Thomas S. Lin, MD, PhD, Randy L. Davis, DrPH, Nedjad Losic, MSC, Steen Lisby, MD, DMSC, John A. Radford, MD
Journal: Blood
Blood (2010) 116 (21): 3955.
https://doi.org/10.1182/blood.V116.21.3955.3955
Published: 2010
Journal Articles

Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma.

Anton Hagenbeek, Luis Fayad, Vincent Delwail, Jean Francois Rossi, Eric Jacobsen, Kazimierz Kuliczkowski, Brian K Link, Lauren Pinter-Brown, John Radford, Andrzej Hellmann, Eve Gallop-Evans, Ira Gupta, Michael Arning, Kamilla Begtrup, Martin Schultz, Bo Bang, Charlotte A Russell, Myron S Czuczman
Journal: Blood
Blood (2009) 114 (22): 935.
https://doi.org/10.1182/blood.V114.22.935.935
Published: 2009